Management and outcome of hepatocellular adenoma with massive bleeding at presentation

Table 3 Tumor features and follow-up

Case no.	Diameter HCA at diagnosis (mm)	Location of HCA	Elective treatment of HCA	Last known HCA diameter (mm)
Initially conservatively treated
1	200	Right lateral (sVI/VII)	Surveillance	6
2	76	Right lateral (sVI/VII)	Surveillance	22
3	60	Right lateral (sVI)	Surveillance	26
4	80	Right medial (sVIII)	Surveillance	53
5	80	Right lateral (sVI)	Resection	-
6	75	Right lateral (sVI/VII)	RFA	0
7	75	Right lateral (sVI/VII)	Surveillance	8
8	143	Right medial (sVIII)	Surveillance	35
9	45	Right medial (sV/VIII)	Surveillance	40
10	39	Right lateral (sVII)	Surveillance	18
11	50	Right medial (sV)	Surveillance	21
12	92	Right lateral (sVI/VII)	Surveillance	43
13	111	Left lateral (sII/III)	Surveillance	92
Initially treated with intervention
14	90	Central (sIV/VIII)	No adenoma tissue after resection	-
15	55	Right medial (sVIII)	Surveillance	20
16	40	Right medial (sV/VIII)	RFA	0
17	73	Central (sIV/VIII)	Surveillance	40
18	80	Right lateral (sVI/VIII)	Surveillance	24
19	100	Left lateral (sII/III)	Surveillance	45
20	100	Central (sIV/V/VIII)	SAE	42
21	55	Right lateral (sVII)	Surveillance	38
22	25	Left lateral (sIII)	Surveillance	17
23	87	Right lateral (sVII)	Surveillance	62

RFA: Radiofrequency ablation; s: Liver segment; SAE: Selective arterial embolization. HCA: Hepatocellular adenoma.